Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma.
Erminia Massarelli
No relevant relationships to disclose
Lawrence E. Ginsberg
No relevant relationships to disclose
Heather Lin
No relevant relationships to disclose
Hai T. Tran
No relevant relationships to disclose
J. Jack Lee
No relevant relationships to disclose
Michelle D. Williams
No relevant relationships to disclose
George R. Blumenschein
No relevant relationships to disclose
Charles Lu
No relevant relationships to disclose
Merrill S. Kies
No relevant relationships to disclose
Vassiliki Papadimitrakopoulou
Research Funding - Astellas Pharma; Novartis